Low concentration of serum haptoglobin has impact on understanding complex pathophysiology in patients with acquired bone marrow failure syndromes

International Journal of Hematology

Volumn 91, Issue 4, 2010, Pages 602-610

  Shichishima, Tsutomu ^a,j   Ikeda, Kazuhiko ^a   Takahashi, Naoto ^b   Kameoka, Junichi ^c   Tajima, Katsushi ^d   Murai, Kazunori ^e   Tamai, Yoshiko ^f   Shichishima Nakamura, Akiko ^a   Akutsu, Kazuko ^a   Noji, Hideyoshi ^a   Okamoto, Masatoshi ^g   Kimura, Hideo ^h   Harigae, Hideo ^c   Oyamada, Takashi ^c,i   Kamesaki, Toyomi ⁱ   Takeishi, Yasuchika ^a   Sawada, Kenichi ^b  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b AKITA UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d YAMAGATA UNIVERSITY   (Japan)

^e IWATE MEDICAL UNIVERSITY   (Japan)

^f HIROSAKI UNIVERSITY HOSPITAL   (Japan)

^g Ohta Nishino uchi Hospital   (Japan)

^h FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

ⁱ JICHI MEDICAL UNIVERSITY   (Japan)

^j Fukushima Research Institute of Environment and Medicine   (Japan)

more..

Author keywords

Acquired bone marrow failure syndromes; Complement mediated hemolysis; Coombs negative autoimmune hemolytic anemia; Ineffective hematopoiesis; Serum haptoglobin

Indexed keywords

ANDROGEN; CYTARABINE; HAPTOGLOBIN; HEMOGLOBIN; HYDROXYUREA; IRON; PREDNISOLONE; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; WARFARIN;

ADULT; AGED; APLASTIC ANEMIA; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD LEVEL; BONE MARROW DEPRESSION; CONCENTRATION (PARAMETERS); COOMBS TEST; ERYTHROPOIESIS; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNORADIOMETRIC ASSAY; IRON BLOOD LEVEL; JAPANESE; LEUKOCYTE COUNT; LEUKOCYTE STRUCTURE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; NEUTROPHIL COUNT; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PATHOPHYSIOLOGY; THROMBOCYTE COUNT;

ADULT; AGED; ANEMIA, APLASTIC; ANEMIA, HEMOLYTIC, AUTOIMMUNE; BONE MARROW DISEASES; COMPLEMENT SYSTEM PROTEINS; COOMBS' TEST; ERYTHROCYTES; FEMALE; GENE FREQUENCY; HAPLOTYPES; HAPTOGLOBINS; HEMATOPOIESIS; HEMOGLOBINURIA, PAROXYSMAL; HEMOLYSIS; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES;

EID: 77954543066     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0559-z     Document Type: Article

References (33)

1. Young NS. The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated. Blood. 1992;79:1385-1392
2. Shichishima T, Noji H. A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria. Hematology. 2002;7:211-227
3. Wang H, Chuhjo T, Yasue S, Omine M, Nakao S. Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria- type cells in bone marrow failure syndromes. Blood. 2002;100:3897-3902
4. Sugimori C, Chuhjo T, Feng X, Yamazaki H, Takami A, Teramura M, et al. Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia. Blood. 2006;107:1308-1314
5. Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 2005;106:3699-3709
6. Wejman JC, Hovsepian D, Wall JS, Hainfeld JF, Greer J. Structure of haptoglobin and the haptoglobin-hemoglobin complex by electron microscopy. J Mol Biol. 1984;174:319-341 (Pubitemid 15011743)
7. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, et al. Identification of the haemoglobin scavenger receptor. Nature. 2001;409:198-201.
8. Gabay C, Kushner I. Acute-phase proteins and other systemic response to inflammation. N Engl J Med. 1999;340:448-454
9. Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem. 1996;42:1589-1600
10. Shinton NK, Richardson RW, Williams JDF. Diagnostic value of serum haptoglobin. J Clin Path. 1965;18:114-118
11. Owen JA, Smith R, Padanyi R, Martin R. Serum haptoglobin in disease. Clin Sci. 1964;26:1-6.
12. International Agranulocytosis and Aplastic Anemia Study. Incidence of aplastic anemia: the releVance of diagnostic criteria. Blood. 1987;70:1718-1721
13. Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogh HG, Herrmann F, et al. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. N Engl J Med. 1991;324:1297-1304
14. Shichishima T, Terasawa T, Hashimoto C, Ohto H, Uchida T, Maruyama Y. Heterogeneous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytes. Br J Haematol. 1991;78:545-550
15. Hall SE, Rosse WF. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood. 1996;87:5332-5340
16. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. The French-American-British (FAB) Cooperative Group. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51:189-199
17. Harris NL, Jaffe ES, Dieboid J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. World Health Organization of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835-3849
18. Lewis SM, Dacie JP. The aplastic anaemia-paroxysmal nocturnal haemoglobinuria syndrome. Br J Haematol. 1967;13:236-251
19. Shichishima T, Terasawa T, Saitoh Y, Hashimoto C, Ohto H, Maruyama Y. Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF. Br J Haematol. 1993;85:378-386
20. Okamoto M, Shichishima T, Noji H, Ikeda K, Nakamura A, Akutsu K, et al. High frequency of several PIG-A mutations in patients with aplastic anemia and myelodysplastic syndrome. Leukemia. 2006;20:627-634
21. Ikeda K, Shichishima T, Yasukawa M, Nakamura-Shichishima A, Noji H, Akutsu K, et al. The role of Wilms' tumor gene peptide-specific cytotoxic T lymphocytes in immunologic selection of a paroxysmal nocturnal hemoglobinuria clone. Exp Hematol. 2007;35:618-626
22. Van Lente F, Marchand A, Galen RS. Evaluation of a nephelometric assay for haptoglobin and its clinical usefulness. Clin Chem. 1979;25:2007-2010
23. Dati F, Schumann G, Thomas L, Aguzzi F, Baudner S, Bienvenu J, et al. Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP reference material (CRM 470). Eur J Clin Chem Clin Biochem. 1996;34:517-520
24. Kirch M, Genth E. Haptoglobin-serumkonzentration und haptoglobin- polymorphismus bei entzündlich-rheumatischen erkrankungen. Medwelt. 1990;41:319-324
25. Jeje MO, Blajchman MA, Steeves K, Horsewood P, Kelton JG. Quantitation of red cell associated IgG using an immunoradiometric assay. Transfusion. 1984;24:473-476
26. Kajii E, Oomi T, Miura S, Ikemoto N. A new approach for diagnosis of autoimmune hemolytic anemia. Jpn J Clin Hematol. 1993;35:336-340
27. Kondo H, Kajii E, Oyamada T, Kasahara Y. Direct antiglobulin test negative autoimmune hemolytic anemia associated with autoimmune hepatitis. Int J Hematol. 1998;68:439-443
28. Shimamoto T, Ohyashiki K. Immunosuppressive treatments for myelodysplastic syndromes. Leuk Lymphoma. 2003;44:593-604.
29. Kamesaki T, Oyamada T, Omine M, Ozawa K, Kajii E. Cut-off value of red-blood-cell-bound IgG for the diagnosis of Coombsnegative autoimmune hemolytic anemia. Am J Hematol. 2009;84:98-101.
30. Theilgaard-Mönch K, Jacobsen LC, Nielsen WJ, Rasmussen T, Udby L, Gharib M, et al. Haptoglobin is synthesized during granulocytes, stored in specific granules, and released by neutrophils in response to activation. Blood. 2006;108:353-361
31. Buckstein R, Jang K, Friedlich J, Zhang L, Reis M, Chesney A, et al. Estimating the prevalence of myelodysplastic syndromes in patients with unexplained cytopenias: a retrospective study of 322 bone marrows. Leuk Res. 2009;33:1313-1318
32. Marsh JCW, Hows JM, Bryett KA, Al-Hashimi S, Fairhead SM, Gordon-Smith EC. Survival after antilymphocyte globulin therapy for aplastic anemia depends on disease severity. Blood. 1987;70:1046-1052
33. Tichelli A, Gratwohl A, Nissen C, Signer E, Gysi CS, Speck B. Morphology in patients with severe aplastic anemia treated with antilymphocyte globulin. Blood. 1992;80:337-345